What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Cardiology
Hisao Ogawa mainly investigates Internal medicine, Cardiology, Myocardial infarction, Endocrinology and Angina.
His study in Coronary artery disease, Endothelium, Coronary arteries, Endothelial dysfunction and Hazard ratio is done as part of Internal medicine.
Hisao Ogawa focuses mostly in the field of Myocardial infarction, narrowing it down to matters related to Stroke and, in some cases, Surgery.
In his study, C-reactive protein is inextricably linked to Placebo, which falls within the broad field of Surgery.
In his research on the topic of Endocrinology, Brain natriuretic peptide is strongly related with Natriuretic peptide.
His research integrates issues of Left coronary artery, Anesthesia and Chest pain in his study of Angina.
His most cited work include:
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (3050 citations)
- Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction (1384 citations)
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. (1210 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Cardiology, Myocardial infarction, In patient and Endocrinology.
His research links Diabetes mellitus with Internal medicine.
Cardiology and Surgery are commonly linked in his work.
He is interested in Unstable angina, which is a branch of Myocardial infarction.
Hisao Ogawa is interested in Endothelial dysfunction, which is a field of Endocrinology.
Hisao Ogawa studies Natriuretic peptide, a branch of Heart failure.
He most often published in these fields:
- Internal medicine (80.17%)
- Cardiology (60.77%)
- Myocardial infarction (20.07%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (80.17%)
- Cardiology (60.77%)
- Myocardial infarction (20.07%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cardiology, Myocardial infarction, Heart failure and In patient.
His study in Internal medicine concentrates on Coronary artery disease, Percutaneous coronary intervention, Hazard ratio, Ejection fraction and Incidence.
His research investigates the link between Hazard ratio and topics such as Type 2 diabetes that cross with problems in Aspirin.
His Cardiology study frequently draws connections between adjacent fields such as Surgery.
The study incorporates disciplines such as Stroke and Clinical endpoint in addition to Myocardial infarction.
The Heart failure study combines topics in areas such as Interquartile range, Adverse effect and Intensive care medicine.
Between 2015 and 2021, his most popular works were:
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (3050 citations)
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial (508 citations)
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial (366 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Cardiology
Hisao Ogawa focuses on Internal medicine, Cardiology, Heart failure, Myocardial infarction and Ejection fraction.
His Internal medicine research is multidisciplinary, incorporating elements of Diabetes mellitus and Surgery.
His Randomized controlled trial study in the realm of Surgery interacts with subjects such as Canakinumab.
His biological study deals with issues like Prospective cohort study, which deal with fields such as Cardiac catheterization.
His studies deal with areas such as Aldosterone, Adverse effect, Cohort study and Intensive care medicine as well as Heart failure.
His work on Unstable angina, Mace and Percutaneous coronary intervention as part of general Myocardial infarction study is frequently linked to Database, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
